An experimental drug appears to slow memory loss. Researchers say people with early Alzheimer’s who got the drug for 18 months experienced 27% less cognitive decline than people who got a placebo.
NPR’s Jon Hamilton reports.
This article was originally published on WBUR.org.
Copyright 2022 NPR. To see more, visit https://www.npr.org.
